Dexcom
Mei Wen Foo is an accomplished professional with extensive experience in the pharmaceutical and medical sectors, currently serving as the Regional Clinical Education Lead for the APAC Region at Dexcom since June 2021. Prior roles include Medical Excellence Consultant and Freelance Medical Writer at LNS Integration, where partnerships with pharmaceutical clients emphasized MSL training and project management in oncology and other specialties. Mei Wen Foo has held leadership positions at Amgen, Sanofi, AstraZeneca, and MSD, contributing to medical capabilities, internal audits, and medical strategy development across various therapeutic areas. A background as a registered pharmacist at The Ministry of Health Malaysia further solidifies expertise in inventory management and quality improvement. Mei Wen Foo holds a Master's degree in Pharmacy from the University of Strathclyde.
This person is not in any offices
Dexcom
45 followers
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes.